HDACs are implicated in the development and progression of cancer through their ability to alter gene expression. Abnormal HDAC activity can lead to the silencing of tumor suppressor genes, promoting uncontrolled cell growth and division. Overexpression or mutation of HDACs has been observed in various types of cancer, including breast, prostate, and colon cancers.
